MedTech Innovator Announces Finalists for Fifth Annual Asia Pacific Competition


Four companies to compete in the Grand Finals hosted by MedTech Innovator in partnership with APACMed 

LOS ANGELES and SINGAPORE – November 24, 2023 – MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the finalists from its 24-company 2023 Asia Pacific Accelerator Cohort. The four finalists include:

  • Healium Medical (Israel): automated dual-mode ultrasound ablation platform for effective atrial fibrillation treatment
  • Medipixel (South Korea): AI-based coronary angio-image analysis system during PCI
  • Module Innovations (India): ultra-rapid detection of antibiotic susceptibility of bacterial infections in hours and not days
  • Vivo Surgical (Singapore): pioneering a flexible endoscope robot for advanced endoscopic surgeries deep within the gastrointestinal tract

Each finalist will receive US$ 10,000 and the chance to compete for the US$ 175,000 non-dilutive Grand Prize. The competitions will take place at the APACMed MedTech Forum, 5-6 December, in Singapore. During the competition finals, which will be held on the plenary stage on Tuesday, December 5, at 1600 hrs SGT, each of the four companies will pitch their technology and answer questions from a panel of renowned industry judges. After the presentations, the audience will vote in real-time to select the winner.

Other awards being presented to the 2023 cohort include the Best Video competition, with a prize of US$ 5,000; a US$ 25,000 in-kind-award from Cambridge Consultants; and the inaugural Olympus Asia Pacific Innovation Program, where the winning innovator will receive grant funding of US$ 75,000 as well as an exclusive mentorship program with key thought leaders from Olympus.

“The companies selected to compete as this year’s finalists have each developed a novel medical technology solution that has the potential to significantly improve patient care, not only in the Asia Pacific region but around the world,” said Fredrik Nyberg, Managing Director Asia Pacific at MedTech Innovator. “We are very impressed by the caliber of companies applying to participate in our program and have thoroughly enjoyed working with our cohort companies over the past year. With support from our industry partners, reviewers, panelists, and APACMed, we have helped our cohort companies accelerate their product development through outstanding corporate mentorship and our tailored educational curriculum. We’re excited to welcome all 24 cohort companies to Singapore on December 5th and 6th!”

Over 400 companies applied for the Asia Pacific program this year, and after a rigorous selection process, 60 companies were invited to pitch, with 24 being selected for the four-month accelerator program. Featuring medical device, diagnostic, and digital health companies from around the globe, the 2023 finalists received unparalleled visibility and access to leading medtech manufacturers, providers, investors, and other industry stakeholders.

MedTech Innovator’s sponsors and partners include Johnson & Johnson MedTech, Olympus, Teleflex, Siemens Healthineers, B Braun Medical, Cambridge Consultants, Jabil Healthcare and Enterprise Singapore, and dozens of community partners.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical technology companies. Its mission is to improve human health by accelerating the growth of companies transforming care. MedTech Innovator has been a catalyst for groundbreaking healthcare solutions, reviewing nearly 10,000 applicants and fostering the growth of 613 companies that have collectively raised over US$ 7.2 billion in follow-on funding and introduced 285 products to the market, transforming the lives of millions.

For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter. Applications for MedTech Innovator Asia Pacific 2024 are now open until January 31, 2024 at .


Branden Morris
Senior Director of Marketing, MedTech Innovator
+1 (978) 770-3799